Literature DB >> 7499834

CD40 signaling-mediated induction of Bcl-XL, Cdk4, and Cdk6. Implication of their cooperation in selective B cell growth.

T Ishida1, N Kobayashi, T Tojo, S Ishida, T Yamamoto, J Inoue.   

Abstract

Signals sent through CD40 play crucial roles in B cell differentiation, including blocking apoptosis of germinal center B cells. In this study, using a murine B cell WEHI-231 line that undergoes apoptosis by the cross-linking of surface Ag receptors (sIgM), we have demonstrated that CD40 signalings are linked to induction of the Bcl-xL, Cdk4, and Cdk6 proteins whose expression was significantly suppressed by the apoptotic signal through sIgM. Mutational analyses of CD40 revealed that the domain of human CD40 required for blocking apoptosis of WEHI-231 cells coincides with that required for Bcl-xL induction. Signals through sIgM arrest cells in the G1 phase of the cell cycle, which is followed by apoptosis. However, while constitutive expression of Bcl-XL leads to the inhibition of apoptosis. Nevertheless, Bcl-xL fails to induce S phase entry. By CD40 signalings, both Cdk4 and Cdk6 resume their normal expression levels, which are sufficient for passing the restriction point in G1 even in the presence of the apoptotic signals mediated by sIgM. These results suggest that cooperation of Bcl-xL, Cdk4, and Cdk6 induced by CD40 signaling plays a key role in CD40-mediated selective growth of B cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7499834

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

1.  Cooperation of multiple signaling pathways in CD40-regulated gene expression in B lymphocytes.

Authors:  Hajir Dadgostar; Brian Zarnegar; Alexander Hoffmann; Xiao-Feng Qin; Uyen Truong; Govinda Rao; David Baltimore; Genhong Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-05       Impact factor: 11.205

Review 2.  Cell cycle control mechanisms in B-1 and B-2 lymphoid subsets.

Authors:  Michael J Piatelli; Debra Tanguay; Thomas L Rothstein; Thomas C Chiles
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

3.  Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20.

Authors: 
Journal:  Nat Genet       Date:  2009-06-14       Impact factor: 38.330

4.  An essential role for Bruton's [corrected] tyrosine kinase in the regulation of B-cell apoptosis.

Authors:  J S Anderson; M Teutsch; Z Dong; H H Wortis
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

Review 5.  Bcl-x and the regulation of survival in the immune system.

Authors:  T W Behrens; D L Mueller
Journal:  Immunol Res       Date:  1997       Impact factor: 2.829

Review 6.  Charting a new course through the chaos of KS (Kaposi's sarcoma)

Authors:  B J Nickoloff; K E Foreman
Journal:  Am J Pathol       Date:  1996-05       Impact factor: 4.307

7.  Pre-assembly of the extracellular domains of CD40 is not necessary for rescue of mouse B cells from anti-immunoglobulin M-induced apoptosis.

Authors:  Peter Ellmark; Christina Furebring; Carl A K Borrebaeck
Journal:  Immunology       Date:  2003-04       Impact factor: 7.397

8.  B-cell receptor- and phorbol ester-induced NF-kappaB and c-Jun N-terminal kinase activation in B cells requires novel protein kinase C's.

Authors:  D Krappmann; A Patke; V Heissmeyer; C Scheidereit
Journal:  Mol Cell Biol       Date:  2001-10       Impact factor: 4.272

9.  Two differently regulated nuclear factor kappaB activation pathways triggered by the cytoplasmic tail of CD40.

Authors:  N Tsukamoto; N Kobayashi; S Azuma; T Yamamoto; J Inoue
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

10.  Specificities of CD40 signaling: involvement of TRAF2 in CD40-induced NF-kappaB activation and intercellular adhesion molecule-1 up-regulation.

Authors:  H H Lee; P W Dempsey; T P Parks; X Zhu; D Baltimore; G Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.